219 related articles for article (PubMed ID: 23324395)
1. Cyclin E2 induces genomic instability by mechanisms distinct from cyclin E1.
Caldon CE; Sergio CM; Burgess A; Deans AJ; Sutherland RL; Musgrove EA
Cell Cycle; 2013 Feb; 12(4):606-17. PubMed ID: 23324395
[TBL] [Abstract][Full Text] [Related]
2. Differences in degradation lead to asynchronous expression of cyclin E1 and cyclin E2 in cancer cells.
Caldon CE; Sergio CM; Sutherland RL; Musgrove EA
Cell Cycle; 2013 Feb; 12(4):596-605. PubMed ID: 23324394
[TBL] [Abstract][Full Text] [Related]
3. Estrogen regulation of cyclin E2 requires cyclin D1 but not c-Myc.
Caldon CE; Sergio CM; Schütte J; Boersma MN; Sutherland RL; Carroll JS; Musgrove EA
Mol Cell Biol; 2009 Sep; 29(17):4623-39. PubMed ID: 19564413
[TBL] [Abstract][Full Text] [Related]
4. Differences in regulation and function of E-cyclins in human cancer cells.
Geng Y; Sicinski P
Cell Cycle; 2013 Apr; 12(8):1165. PubMed ID: 23549169
[No Abstract] [Full Text] [Related]
5. RAD52-dependent mitotic DNA synthesis is required for genome stability in Cyclin E1-overexpressing cells.
Audrey A; Kok YP; Yu S; de Haan L; van de Kooij B; van den Tempel N; Chen M; de Boer HR; van der Vegt B; van Vugt MATM
Cell Rep; 2024 Apr; 43(4):114116. PubMed ID: 38625790
[TBL] [Abstract][Full Text] [Related]
6. Proteomic Landscape of Tissue-Specific Cyclin E Functions in Vivo.
Odajima J; Saini S; Jung P; Ndassa-Colday Y; Ficaro S; Geng Y; Marco E; Michowski W; Wang YE; DeCaprio JA; Litovchick L; Marto J; Sicinski P
PLoS Genet; 2016 Nov; 12(11):e1006429. PubMed ID: 27828963
[TBL] [Abstract][Full Text] [Related]
7. Cyclin E deregulation promotes loss of specific genomic regions.
Teixeira LK; Wang X; Li Y; Ekholm-Reed S; Wu X; Wang P; Reed SI
Curr Biol; 2015 May; 25(10):1327-33. PubMed ID: 25959964
[TBL] [Abstract][Full Text] [Related]
8. Kinase-independent function of E-type cyclins in liver cancer.
Geng Y; Michowski W; Chick JM; Wang YE; Jecrois ME; Sweeney KE; Liu L; Han RC; Ke N; Zagozdzon A; Sicinska E; Bronson RT; Gygi SP; Sicinski P
Proc Natl Acad Sci U S A; 2018 Jan; 115(5):1015-1020. PubMed ID: 29339491
[TBL] [Abstract][Full Text] [Related]
9. Cyclin E2 overexpression is associated with endocrine resistance but not insensitivity to CDK2 inhibition in human breast cancer cells.
Caldon CE; Sergio CM; Kang J; Muthukaruppan A; Boersma MN; Stone A; Barraclough J; Lee CS; Black MA; Miller LD; Gee JM; Nicholson RI; Sutherland RL; Print CG; Musgrove EA
Mol Cancer Ther; 2012 Jul; 11(7):1488-99. PubMed ID: 22564725
[TBL] [Abstract][Full Text] [Related]
10. Cx43 and AKAP95 regulate G1/S conversion by competitively binding to cyclin E1/E2 in lung cancer cells.
Chen R; Chen Y; Yuan Y; Zou X; Sun Q; Lin H; Chen X; Liu M; Deng Z; Yao Y; Guo D; Zhang Y
Thorac Cancer; 2020 Jun; 11(6):1594-1602. PubMed ID: 32338437
[TBL] [Abstract][Full Text] [Related]
11. Cyclin E deregulation impairs mitotic progression through premature activation of Cdc25C.
Bagheri-Yarmand R; Nanos-Webb A; Biernacka A; Bui T; Keyomarsi K
Cancer Res; 2010 Jun; 70(12):5085-95. PubMed ID: 20530684
[TBL] [Abstract][Full Text] [Related]
12. The requirement for cyclin E in c-Myc overexpressing breast cancers.
Zhou Y; Geng Y; Zhang Y; Zhou Y; Chu C; Sharma S; Fassl A; Butter D; Sicinski P
Cell Cycle; 2020 Oct; 19(20):2589-2599. PubMed ID: 32975478
[TBL] [Abstract][Full Text] [Related]
13. Low molecular weight cyclin E overexpression shortens mitosis, leading to chromosome missegregation and centrosome amplification.
Bagheri-Yarmand R; Biernacka A; Hunt KK; Keyomarsi K
Cancer Res; 2010 Jun; 70(12):5074-84. PubMed ID: 20530685
[TBL] [Abstract][Full Text] [Related]
14. Expression of cyclins E1 and E2 during mouse development and in neoplasia.
Geng Y; Yu Q; Whoriskey W; Dick F; Tsai KY; Ford HL; Biswas DK; Pardee AB; Amati B; Jacks T; Richardson A; Dyson N; Sicinski P
Proc Natl Acad Sci U S A; 2001 Nov; 98(23):13138-43. PubMed ID: 11687642
[TBL] [Abstract][Full Text] [Related]
15. Mammalian E-type cyclins control chromosome pairing, telomere stability and CDK2 localization in male meiosis.
Martinerie L; Manterola M; Chung SS; Panigrahi SK; Weisbach M; Vasileva A; Geng Y; Sicinski P; Wolgemuth DJ
PLoS Genet; 2014 Feb; 10(2):e1004165. PubMed ID: 24586195
[TBL] [Abstract][Full Text] [Related]
16. Cyclin E1 and cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinoma.
Sonntag R; Giebeler N; Nevzorova YA; Bangen JM; Fahrenkamp D; Lambertz D; Haas U; Hu W; Gassler N; Cubero FJ; Müller-Newen G; Abdallah AT; Weiskirchen R; Ticconi F; Costa IG; Barbacid M; Trautwein C; Liedtke C
Proc Natl Acad Sci U S A; 2018 Sep; 115(37):9282-9287. PubMed ID: 30150405
[TBL] [Abstract][Full Text] [Related]
17. Cyclin K regulates prereplicative complex assembly to promote mammalian cell proliferation.
Lei T; Zhang P; Zhang X; Xiao X; Zhang J; Qiu T; Dai Q; Zhang Y; Min L; Li Q; Yin R; Ding P; Li N; Qu Y; Mu D; Qin J; Zhu X; Xiao ZX; Li Q
Nat Commun; 2018 May; 9(1):1876. PubMed ID: 29760377
[TBL] [Abstract][Full Text] [Related]
18. SCF(Fbxw7/hCdc4) targets cyclin E2 for ubiquitin-dependent proteolysis.
Klotz K; Cepeda D; Tan Y; Sun D; Sangfelt O; Spruck C
Exp Cell Res; 2009 Jul; 315(11):1832-9. PubMed ID: 19084516
[TBL] [Abstract][Full Text] [Related]
19. Rsf-1, a chromatin remodelling protein, interacts with cyclin E1 and promotes tumour development.
Sheu JJ; Choi JH; Guan B; Tsai FJ; Hua CH; Lai MT; Wang TL; Shih IeM
J Pathol; 2013 Mar; 229(4):559-68. PubMed ID: 23378270
[TBL] [Abstract][Full Text] [Related]
20. Concurrent deletion of cyclin E1 and cyclin-dependent kinase 2 in hepatocytes inhibits DNA replication and liver regeneration in mice.
Hu W; Nevzorova YA; Haas U; Moro N; Sicinski P; Geng Y; Barbacid M; Trautwein C; Liedtke C
Hepatology; 2014 Feb; 59(2):651-60. PubMed ID: 23787781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
